Akums has been awarded the title of 'Game Changers in Disease Diagnosis' at the 5th Healthcare Heroes Award event, organized by Only My Health and conceptualized by Jagran New Media. The award was presented by the Honorable Health Minister of Delhi, Sri Pankaj Kumar Singh, who also oversees the Transport and Information Technology ministries. A senior team member from Akums Drugs & Pharmaceuticals Limited accepted the award on behalf of the company. It was a moment of great pride for the entire team as their groundbreaking development, Hydroxyurea, was also honored with the Editor's Choice Award.
Hydroxyurea: Medicine That Made Them Win
Hydroxyurea is a pioneering, indigenous medicine developed by Akums' R&D team, specifically for Sickle Cell Anemia. This genetic blood disorder causes red blood cells to become rigid and sickle-shaped, leading to pain crises, anemia, and potential organ damage.
Prior to this local innovation, the international counterpart of the drug was extremely expensive, costing around INR 77,000 for 100 ml and requiring freezing temperatures to maintain its effectiveness. In contrast, Akums' indigenous Hydroxyurea is priced under INR 1,000 for 100 ml and remains stable at room temperature, making it an affordable and accessible option for Sickle Cell.
Top Stories
-1751527287915.png)
-1751352905978.jpg)
Innovation & Sustainability: The Two Pillars for Success
On this proud occasion, Shri Sandeep Jain, Founder & Managing Director of Akums, expressed his delight in receiving the award, stating, "We are thrilled to receive this recognition, as it reflects our dedication and commitment to addressing critical illnesses. We extend our heartfelt gratitude to our R&D teams, whose hard work has significantly contributed to the 'Make in India' initiative. Akums has always been at the forefront of innovation and sustainability, and we take great pride in this. We would also like to thank the jury members and editorial team for their trust in us and for selecting Akums for this honor.”
Recently, Akums has successfully installed a 600 kWp on-grid rooftop solar power plant on its warehouse premises in Haridwar, Uttarakhand. The grid-connected solar panel, placed across a 56,000 sq. ft. region on the rooftop, is anticipated to produce more than 7.5 lakh units of solar power each year, according to calculations of trapping sunlight for 5 hours daily. Through this solar power plant and generation of clean energy, Akums will lower its carbon footprint and lead the mission for renewable energy, further establishing the company's commitment to environmental stewardship.
Akums: Revolutionising Pharmaceutical Manufacturing & Delivery
Akums is the largest India-focused CDMO, a pioneer in pharmaceutical manufacturing and dedicated to delivering high-quality medicines at reasonable prices. With a strong emphasis on innovation, sustainability, and social responsibility, Akums is committed to enhancing the health and well-being of individuals across the globe while working towards a better, more sustainable future.
The company has a strong presence in 7 Indian states and effectively operates 15 manufacturing facilities and 5 R&D units, wherein about 400 scientists continuously work on innovation to enhance patient care. With a committed staff of more than 16,000 employees, Akums' turnover for the period FY2024-25 is INR 4,212 crores.
In 2024, Akums planted over 5,000 trees and has set a target of planting over 10,000 trees in 2025, both in and around its premises. Besides native tree plantations and propagating indigenous flora and fauna, Akums is also actively engaging with the Clean Ganga Mission to ensure that plastic pollution is curbed.
With these efforts, Akums is well ahead on its path of sustainability as well as developing a culture of sustainability within its workforce.